0001622240-15-000001.txt : 20150203 0001622240-15-000001.hdr.sgml : 20150203 20150203115239 ACCESSION NUMBER: 0001622240-15-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150203 DATE AS OF CHANGE: 20150203 EFFECTIVENESS DATE: 20150203 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Supreme Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001622240 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-233350 FILM NUMBER: 15569685 BUSINESS ADDRESS: STREET 1: SUITE #430, 580 HORNBY STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 3B6 BUSINESS PHONE: 604-674-2191 MAIL ADDRESS: STREET 1: SUITE #430, 580 HORNBY STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 3B6 D 1 primary_doc.xml X0707 D LIVE 0001622240 Supreme Pharmaceuticals Inc. SUITE #430, 580 HORNBY STREET VANCOUVER A1 BRITISH COLUMBIA, CANADA V6C 3B6 604-674-2191 BRITISH COLUMBIA, CANADA None None Corporation true Chris Bechtel 31 Cape Harbour Pl. The Woodlands TX TEXAS 77380 Director John Fowler Suite #430 580 Hornby Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 3B6 Executive Officer Director Allan Levien Suite #430 580 Hornby Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 3B6 Director Tatiana Kovaleva Suite #430 580 Hornby Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 3B6 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2015-01-23 false true false 0 116985 116985 0 false 3 0 0 0 false Supreme Pharmaceuticals Inc. John Fowler John Fowler President and Director 2015-01-29